[Multiple sclerosis (MS), an inflammatory or degenerative disease?].
Confavreux
Christian
C
Vukusic
Sandra
S
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D002908:Chronic Disease; D015331:Cohort Studies; D004195:Disease Models, Animal; D005544:Forecasting; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D051379:Mice; D008942:Mitoxantrone / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D010455:Peptides / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D008942:Mitoxantrone